Atrial Fibrillation Atrial Flutter - Revision history

Treloars: /* STABLE: */

2025-06-23T14:31:22Z

STABLE:

← Older revision		Revision as of 14:31, 23 June 2025
Line 8:		Line 8:
	* Thyroid Disease.		* Thyroid Disease.

	==== ~~STABLE~~: ====		==== POTENTIALLY UNSTABLE AND TIME TO ED > 15 MINUTES: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Oxygen\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Oxygen\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. ~~Administer~~ [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Consider administration of [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[Aspirin\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Aspirin\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

Treloars at 14:45, 24 April 2020

2020-04-24T14:45:49Z

← Older revision		Revision as of 14:45, 24 April 2020
Line 12:		Line 12:
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[~~Salicylates~~\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Aspirin\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''

Treloars at 14:32, 24 April 2020

2020-04-24T14:32:46Z

← Older revision		Revision as of 14:32, 24 April 2020
Line 9:		Line 9:

	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[~~Medical Gases~~\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Oxygen\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
Line 18:		Line 18:

	==== UNSTABLE: ====		==== UNSTABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01)- [[~~Medical Gases~~\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01)- [[Oxygen\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	*O2 saturation, monitor in place.		*O2 saturation, monitor in place.
	* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.		* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.

Treloars at 14:01, 24 April 2020

2020-04-24T14:01:12Z

← Older revision		Revision as of 14:01, 24 April 2020
Line 21:		Line 21:
	*O2 saturation, monitor in place.		*O2 saturation, monitor in place.
	* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.		* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.
	*Consider pre-medication with [[~~Sedative Hypnotics~~\|MIDAZOLAM (VERSED)]]. Start at 2-5 mg then 2 mg every 30 seconds to 1 min IVP or IN if patient is conscious.		*Consider pre-medication with [[Versed\|MIDAZOLAM (VERSED)]]. Start at 2-5 mg then 2 mg every 30 seconds to 1 min IVP or IN if patient is conscious.
	*May repeat as necessary to allow for sedation. See [[Analgesia and Sedation\|ANALGESIA/SEDATION PARAMETER]] (2.04)		*May repeat as necessary to allow for sedation. See [[Analgesia and Sedation\|ANALGESIA/SEDATION PARAMETER]] (2.04)
	* If NO response, [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 100 Joules.		* If NO response, [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 100 Joules.

Treloars at 23:48, 23 April 2020

2020-04-23T23:48:06Z

← Older revision		Revision as of 23:48, 23 April 2020
Line 10:		Line 10:
	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''
	'''''Use in these situations can result in severe bradycardia and refractory hypotension or cardiac arrest.'''''		'''''Use in these situations can result in severe bradycardia and refractory hypotension or cardiac arrest.'''''

Treloars: /* STABLE: */

2020-03-09T15:01:44Z

STABLE:

← Older revision		Revision as of 15:01, 9 March 2020
Line 10:		Line 10:
	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 ~~minutes if the patient contact and transport time is greater than 25~~ minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

Treloars at 15:41, 1 February 2018

2018-02-01T15:41:03Z

← Older revision		Revision as of 15:41, 1 February 2018
Line 34:		Line 34:
	'''''If there is a prolonged delay or difficulty obtaining synchronization, and the patient is extremely UNSTABLE, then [[Defibrillation\|DEFIBRILLATION]] should be administered.'''''		'''''If there is a prolonged delay or difficulty obtaining synchronization, and the patient is extremely UNSTABLE, then [[Defibrillation\|DEFIBRILLATION]] should be administered.'''''

	[[Category:Cardiac]]		[[Category:Cardiac\|0403]]

Treloars: /* Section 4 - CARDIAC */

2017-06-29T17:38:11Z

Section 4 - CARDIAC

← Older revision		Revision as of 17:38, 29 June 2017
Line 12:		Line 12:
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
			* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''

Treloars: /* STABLE: */

2016-04-25T18:32:41Z

STABLE:

← Older revision		Revision as of 18:32, 25 April 2016
Line 10:		Line 10:
	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg ~~IVP~~ if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg ~~IVP~~		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)

Treloars: /* Section 4 - CARDIAC */

2012-04-02T01:12:18Z

Section 4 - CARDIAC

← Older revision		Revision as of 01:12, 2 April 2012
Line 32:		Line 32:

	'''''If there is a prolonged delay or difficulty obtaining synchronization, and the patient is extremely UNSTABLE, then [[Defibrillation\|DEFIBRILLATION]] should be administered.'''''		'''''If there is a prolonged delay or difficulty obtaining synchronization, and the patient is extremely UNSTABLE, then [[Defibrillation\|DEFIBRILLATION]] should be administered.'''''

			[[Category:Cardiac]]

← Older revision		Revision as of 14:45, 24 April 2020
Line 12:		Line 12:
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[~~Salicylates~~\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Aspirin\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''

← Older revision		Revision as of 14:01, 24 April 2020
Line 21:		Line 21:
	*O2 saturation, monitor in place.		*O2 saturation, monitor in place.
	* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.		* [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 50 Joules.
	*Consider pre-medication with [[~~Sedative Hypnotics~~\|MIDAZOLAM (VERSED)]]. Start at 2-5 mg then 2 mg every 30 seconds to 1 min IVP or IN if patient is conscious.		*Consider pre-medication with [[Versed\|MIDAZOLAM (VERSED)]]. Start at 2-5 mg then 2 mg every 30 seconds to 1 min IVP or IN if patient is conscious.
	*May repeat as necessary to allow for sedation. See [[Analgesia and Sedation\|ANALGESIA/SEDATION PARAMETER]] (2.04)		*May repeat as necessary to allow for sedation. See [[Analgesia and Sedation\|ANALGESIA/SEDATION PARAMETER]] (2.04)
	* If NO response, [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 100 Joules.		* If NO response, [[Cardioversion\|SYNCHRONIZED CARDIOVERSION]] @ 100 Joules.

← Older revision		Revision as of 23:48, 23 April 2020
Line 10:		Line 10:
	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Cardizem\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[~~Antiarrhythmics~~\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Cardizem\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''
	'''''Use in these situations can result in severe bradycardia and refractory hypotension or cardiac arrest.'''''		'''''Use in these situations can result in severe bradycardia and refractory hypotension or cardiac arrest.'''''

← Older revision		Revision as of 15:01, 9 March 2020
Line 10:		Line 10:
	==== STABLE: ====		==== STABLE: ====
	* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.		* [[Initial Medical Assessment and Care\|INITIAL MEDICAL CARE]] (2.01) - [[Medical Gases\|OXYGEN]] @ 100% via NRB mask or assist with BVM.
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 ~~minutes if the patient contact and transport time is greater than 25~~ minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
	* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.		* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

← Older revision		Revision as of 17:38, 29 June 2017
Line 12:		Line 12:
	* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes		* If rate is greater than 150 beats/minute and narrow complex. Administer [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.25 mg/kg IV bolus over 2 minutes if the patient contact and transport time is greater than 25 minutes. If no response in 30 minutes and heart rate greater than 150, [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] 0.35 mg/kg IV bolus over 2 minutes
	* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)		* If rate greater than 150 beats/minute and wide complex refer to [[Wide Complex Tachycardia Uncertain Origin\|WIDE COMPLEX TACHYCARDIA PARAMETER]] (4.10)
			* [[Salicylates\|ASPIRIN]] 81mg, chewed, if not previously administered or with known hypersensitivity to the drug or active ulcer disease.

	'''''BLACK BOX WARNING: [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''		'''''BLACK BOX WARNING: [[Antiarrhythmics\|DILTIAZEM (CARDIZEM)]] IS CONTRAINDICATED IN HYPOVOLEMIA AND CALCIUM CHANNEL BLOCKER USE.'''''